(Q88978493)
Statements
First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients (English)
0 references
Hongyi Chen
0 references
Zhicheng Zhang
0 references
Li Wang
0 references
Zhihua Huang
0 references
Fanghua Gong
0 references
Xiaodong Li
0 references
Yahong Chen
0 references
Jinzi J. WU
0 references
24 March 2020
0 references